Clinical Trials
5 trialsNCT07582887 2026-05-13
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Recruiting
NCT07264985 2025-12-04
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Hubei Cancer Hospital
Not yet recruiting
NCT05078190 2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT06558084 2024-08-16
Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
Ain Shams University
Completed
NCT05266300 2022-11-01
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
University of Southern Denmark
Completed